| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |